Mycotopia Therapies, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Mycotopia Therapies, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Mycotopia Therapies, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$391K, a 234% decline year-over-year.
  • Mycotopia Therapies, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$1.11M, a 54.6% decline year-over-year.
  • Mycotopia Therapies, Inc. annual Operating Income (Loss) for 2023 was -$617K, a 64.5% increase from 2022.
  • Mycotopia Therapies, Inc. annual Operating Income (Loss) for 2022 was -$1.74M, a 65.2% increase from 2021.
  • Mycotopia Therapies, Inc. annual Operating Income (Loss) for 2021 was -$4.99M, a 34963% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$617K +$1.12M +64.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-23
2022 -$1.74M +$3.25M +65.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-23
2021 -$4.99M -$4.97M -34963% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-11-06
2020 -$14.2K +$237K +94.4% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-10-17
2019 -$252K -$65.6K -35.3% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-30
2018 -$186K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.